<DOC>
	<DOCNO>NCT01513694</DOCNO>
	<brief_summary>The purpose trial test effectiveness use new therapeutic strategy treat patient degenerative disc disease lumbar intervertebral fusion instrument posterolateral autologous mesenchymal stem cell arrange calcium phosphate ceramic ( Conduit TM ) .</brief_summary>
	<brief_title>Clinical Trial Based Use Mesenchymal Stem Cells From Autologous Bone Marrow Patients With Lumbar Intervertebral Degenerative Disc Disease</brief_title>
	<detailed_description />
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<criteria>Clinical Box symptomatic ( back pain / root ) lumbar degenerative disc disease monosegmental . Discopathy refractory conservative treatment ( drug , physical therapy . ) Evolution great equal 6 month . Radiological Discopathy radiation . Disc space narrowing , osteophytes , abnormal mobility , etc NMR : grade IV V Pfirman . Rejection surgical treatment . Systemic inflammatory disease ( spondylitis , rheumatoid arthritis etc ) , tumor infection . Immunosuppressive treatment . Congenital acquire anatomical abnormality prevents surgical procedure . Neuropsychiatric pathology , drug addiction , psychosis , severe personality disorder . High surgical risk ( ASA &gt; IV ) , contraindication anesthesia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Mesenchymal Stem Cells</keyword>
	<keyword>Stem Cells</keyword>
	<keyword>Intervertebral disc disease</keyword>
</DOC>